BTL’s Emface device treats facial skin for wrinkles and increases muscle tone simultaneously without the need for injections or needles.
BTL has unveiled Emface, a hands-free device that simultaneously treats facial skin and muscles without needles in four 20-minute sessions.
Emface simultaneously emits both synchronized radio frequency and HIFES-brand energies.
The homogenous radio frequency heats collagen and elastin fibers while the HIFES stimulation emits thousands of pulses per session to contract delicate facial muscles.
The recommended treatment course for the EMFACE therapy calls for four 20-minute sessions, with each session completed 2-14 days apart.
BTL’s clinical research of Emface showed the treatment results in fewer wrinkles and more lift.
The findings from 9 clinical studies concluded that participants who completed the recommended treatment course experienced, on average, a 37% reduction in wrinkles, a 30% increase in facial muscle tone, and a 23% lifting effect. Optimal results were seen 6-12 weeks after the final treatment.
The 2-in-1 procedure is needle- and injectable-free and requires no pre- or post-preparation or downtime.
“When the innovative Emsculpt surprised the aesthetics market in 2018, BTL committed to continued investment in creating an extensive pipeline of groundbreaking therapies,” said Scott Mills, President of BTL. “Utilizing 20+ years of institutional knowledge we continue to round out the body solutions with our Emsculpt Neo platform and have our sights set on tackling facial applications with the Emface platform.”